GSK-200909

Study Sponsor: GSK

Study Title

A single dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK1550188 in Chinese subjects with Systemic Lupus Erythematosus (SLE)

Medicine or Vaccine (generic name)

belimumab

Sponsor Identification Number

200909

Trial Registry Identification Number(#'s)

NCT02880852

Medical Condition

Systemic Lupus Erythematosus

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=200909

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02880852

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

February 2020